REGENXBIO Inc. (RGNX)

REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	130.1	57.53	34.52	96.95	345.21	338.43
Short-Term Investments	137.77	177.16	240.74	267.69	112.23	137.31
Cash & Short-Term Investments	267.87	234.69	275.26	364.64	457.44	475.74
Cash Growth	-20.91%	-14.74%	-24.51%	-20.29%	-3.85%	60.61%
Accounts Receivable	18.19	20.47	24.79	28.08	28.51	43.35
Other Receivables	15.05	12.4	19.3	8.5	-	-
Receivables	33.24	32.87	44.09	36.59	28.51	43.35
Prepaid Expenses	11.09	9.07	14.52	13.9	18.75	10.51
Other Current Assets	1.04	1.38	1.11	0.85	14.12	1.6
Total Current Assets	313.24	278	334.97	415.98	518.83	531.2
Property, Plant & Equipment	166.61	171.31	192.59	206.8	192.45	120.28
Long-Term Investments	4.86	10.18	38.87	200.56	391.91	47.91
Long-Term Accounts Receivable	1.21	0.47	0.7	1.5	2.26	3.27
Other Long-Term Assets	5.02	6.03	6.84	8.43	8.46	5.51
Total Assets	490.93	465.99	573.97	833.27	1,114	708.16
Accounts Payable	19.04	22.8	22.79	27.21	11.39	10.62
Accrued Expenses	23.56	37.91	49.32	45.99	59.5	38.09
Current Portion of Long-Term Debt	42.56	34.31	50.57	48.6	37.89	18.79
Current Portion of Leases	7.94	7.9	7.07	6	1.75	2.5
Current Income Taxes Payable	-	-	-	-	11.33	3.14
Current Unearned Revenue	13.59	0.12	0.15	1.83	3.33	0.45
Other Current Liabilities	0.04	0.16	0.39	0.81	5.29	7.85
Total Current Liabilities	106.73	103.19	130.27	130.43	130.47	81.45
Long-Term Debt	11.12	25.38	43.49	89.01	133.46	174.5
Long-Term Leases	71.91	74.13	82.22	88.8	84.93	70.15
Long-Term Unearned Revenue	26.3	-	-	-	-	3.78
Other Long-Term Liabilities	0.68	3.64	6.25	8.83	0.75	0.52
Total Liabilities	216.73	206.34	262.23	317.07	349.61	330.41
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	1,201	1,193	1,021	973.15	928.1	667.18
Retained Earnings	-926.07	-932.15	-705.05	-441.55	-161.23	-289.07
Comprehensive Income & Other	-0.76	-0.74	-4.43	-15.4	-2.57	-0.36
Total Common Equity	274.2	259.65	311.74	516.2	764.3	377.75
Shareholders' Equity	274.2	259.65	311.74	516.2	764.3	377.75
Total Liabilities & Equity	490.93	465.99	573.97	833.27	1,114	708.16
Total Debt	133.53	141.72	183.34	232.41	258.03	265.95
Net Cash (Debt)	139.2	103.15	130.79	332.8	591.32	256.6
Net Cash Growth	-33.70%	-21.13%	-60.70%	-43.72%	130.45%	-33.99%
Net Cash Per Share	2.73	2.08	2.99	7.71	13.47	6.88
Filing Date Shares Outstanding	50.16	50.09	44.43	43.46	42.95	42.5
Total Common Shares Outstanding	50.12	49.55	44.05	43.3	42.83	37.48
Working Capital	206.51	174.81	204.7	285.54	388.35	449.75
Book Value Per Share	5.47	5.24	7.08	11.92	17.84	10.08
Tangible Book Value	274.2	259.65	311.74	516.2	764.3	377.75
Tangible Book Value Per Share	5.47	5.24	7.08	11.92	17.84	10.08
Machinery	89.15	88.42	87.38	83.68	68.05	34.18
Leasehold Improvements	101.52	101.47	101.93	99.4	92.54	44.96

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q